Industry Playbooks
Research workflows for day traders are the systematic processes for instrument research, catalyst identification, setup development, and pre-market preparation — enabling traders to enter each session with a documented watch list and clear trade plans rather than making real-time decisions with insufficient preparation.
Most day traders research in real time. The market opens, they watch for movement, they read news as it comes across, they make decisions based on whatever information is currently in front of them. This feels like trading with market awareness. It's actually trading with incomplete, unstructured information in the highest-pressure decision-making environment possible.
Research workflows for day traders are the systematic processes that move research before the market opens — building a documented watch list with researched setups before the session, not discovering what to trade after the opening bell. The trader who enters the session with three researched candidates, each with a documented thesis, key levels, and trade plan, has a structural advantage over the trader who decides in real time.
Pre-market catalyst identification: Why is a specific instrument moving today? News-driven moves (earnings, FDA decisions, analyst upgrades/downgrades, contract wins, legal settlements, macro data releases) have different characteristics than purely technical moves. Knowing the catalyst before the session determines how to approach the trade.
Technical context: Where is the instrument in its chart structure? Key levels (support, resistance, moving averages, prior highs/lows), volume profile, and trend context determine how much room a trade has to run and where it's likely to stall or reverse.
Pre-planned trade scenarios: The best trade planning happens before the session, not during it. For each watch list candidate: if X happens, I do Y. "If the stock holds above $45 after the opening range, I'll look for the first pullback to the 9EMA as an entry opportunity." This is a trade plan. "Let me see what happens" is a recipe for reactive, poorly timed decisions.
Session awareness: Macro backdrop, sector rotation, market volatility (VIX), and pre-market futures all affect how individual trades are likely to behave. Knowing the macro context before the session opens allows calibration of position size and risk tolerance.
The best time for research is not 9:30am.
The evening before each trading session, run the screening and research process that builds the next day's watch list:
Scanning for candidates:
For each candidate, build a research note:
Result: A watch list of 3-5 candidates with documented research, not just ticker symbols.
30-60 minutes before the open:
What to do if overnight developments change the thesis: If news or pre-market activity fundamentally changes the thesis for a candidate, remove it from the watch list or update the plan to reflect the new information. This happens regularly; it's not a research failure, it's the research workflow doing what it's supposed to do.
The goal is to execute pre-planned setups, not to discover new trades.
During the session:
Limiting real-time research: Real-time "discovery" of new trades during the session is the research workflow failure mode. A stock that starts moving at 10:15am has not been researched; chasing it is a different activity than executing a researched setup. Some traders allow themselves to research new opportunities during the session; most find this leads to lower-quality trades than pre-session preparation.
30-60 minutes after the close:
The post-session review is the learning loop: Without a structured post-session review that compares what you planned to what happened, the trading session provides data but not learning. The review is what converts experience into improvement.
| Stage | Tool | Notes |
|---|---|---|
| Scanning | Finviz, Trade-Ideas, brokerage scanner | Stock screener for catalysts and technicals |
| Earnings calendar | Earnings Whispers, Bloomberg | Pre-market catalyst identification |
| News monitoring | Bloomberg, Reuters, MarketWatch | Real-time news feeds |
| SEC filings | SEC EDGAR, company IR pages | 8-K filings for material announcements |
| Chart analysis | TradingView | Key level identification, annotated setups |
| Watch list and research | Notion, trading journal app | Structured watch list notes |
| Web research capture | WebSnips | Clip filings, news, research with date/URL |
WebSnips for day trader research: Catalyst-driven trading requires access to the specific documents that drive catalyst moves — SEC 8-K filings, FDA approval letters, company press releases, analyst report summaries, earnings transcripts. WebSnips captures specific pages with date and source URL. A clip of an 8-K filing announcing a contract win, with the publication timestamp, is the documented basis for a trade thesis. When an analyst upgrades a stock and the summary appears on a financial news site, a dated clip with source URL is the retrievable record that links the catalyst to the trade. Organized by collection (Watch List Research, Sector Catalysts, Macro Context), WebSnips clips build the pre-session research library that structured trade plans reference.
For catalyst-driven trades specifically, the date and time of information is legally and analytically significant. Capturing when a piece of public information was first available — and trading only on publicly available information — is both research discipline and legal compliance.
A day trader, Sarah Kim, specializes in biotech catalyst trades. Her research workflow for a high-profile FDA decision day:
Previous evening — research build:
Instrument: BIOX Corp
Catalyst: FDA PDUFA date for their lead drug NovaTreat — decision expected October 14, 2026 (confirmed via FDA calendar)
Research note (built evening of October 13):
Thesis: FDA decision on NovaTreat tomorrow. Drug has priority review designation; analyst consensus is 70% probability of approval. Phase 3 trials showed statistically significant primary endpoint. Market is pricing a ~15% expected move (based on options implied volatility).
Key levels:
Trade scenarios:
Approval scenario (probability: ~70% per analyst consensus): Gap up expected. DO NOT CHASE the open — wait for the opening range (9:30-9:45am) to establish. Entry: if stock holds above $25 through the first 30-minute candle close, look for continuation play above OR high. Target: $28-29 (Fibonacci extension and prior resistance). Stop: below OR low or below $24 (whichever is less risk). Maximum position size: 2% account risk.
Rejection scenario (probability: ~30%): Stock will gap down significantly. If it opens below $18, do not short into a panic — wait for a dead cat bounce setup (typically appears 30-60 minutes after the open as initial panic subsides). Short entry: if stock bounces to $17-18 and fails, short with stop above $19. Target: $13-14.
No trade scenario: If the decision is delayed or if FDA issues a Complete Response Letter (CRL) rather than outright rejection, uncertainty may keep the stock range-bound. No trade in range-bound catalyst confusion.
Risk factors: FDA can issue approval with significant label restrictions that markets may interpret negatively even though technically an approval. Know the label issue risk before entering an approval-scenario trade.
WebSnips clips linked: [FDA PDUFA calendar page, dated], [Phase 3 trial results summary from company IR page, dated], [options flow analysis showing expected move, dated October 12]
Pre-market, October 14 (8:00am):
FDA approval announced at 7:15am. Stock is trading at $27.80 in pre-market, up 24%. Revising trade plan:
Updated note: Drug approved with clean label (no major restrictions). Pre-market trading at $27.80. Opening range will likely form around $25-28 territory given pre-market volume. Adjust key levels: primary resistance now $30-31 (options strike concentration); support on pullback at $26 (gap fill from pre-market). Scenario: opening at $27.80+, look for opening range above $27 as the new setup anchor.
Session — 9:37am: BIOX established opening range $26.90-$28.20. Entry at $28.25 (OR high breakout). Stop at $26.80. Target $31.
Session — 10:15am: Exit at $30.40 as stock stalled at $31 resistance for 3 candles. P&L: +2.1R. ✓ Followed the plan.
Post-session journal entry: "Setup worked as planned. Pre-market revision correctly identified new key levels based on FDA label news. Did not chase the open — waited for OR, which protected from the 10-minute pullback to $27.20 that happened right at open. Research done night before meant I had context for the label issue risk; when the approval came with clean label, I had confidence to trade the setup."
Material non-public information (MNPI): Trading on MNPI is illegal under securities law (SEC Rule 10b-5). All research and trading should be based exclusively on publicly available information. If you receive information about a company that is not publicly disclosed — from a company employee, an industry contact, or any other non-public source — consult legal counsel before trading. Trading on MNPI is not a gray area; it is securities fraud.
Wash sale rule: If you sell a stock at a loss and buy it back within 30 days (before or after), the IRS wash sale rule disallows the loss for tax purposes. This applies to substantially identical securities. Day traders with high volume may inadvertently trigger wash sales; know the rule and track it.
Pattern Day Trader (PDT) rule: Executing 4 or more day trades in 5 business days in a margin account requires a minimum $25,000 account balance. Know this rule and whether it applies to your account structure.
Mistake 1: Building the watch list after the open. Research done in real time is research done under pressure, with incomplete information, when the market is already moving. Pre-session research builds the watch list before the pressure starts.
Mistake 2: Chasing instead of executing. A stock moving at 10:30am that wasn't on the watch list is an unresearched trade. Chasing it is real-time speculation; executing a watch list trade is implementing a researched plan. Know which one you're doing.
Mistake 3: Watch list without trade scenarios. "BIOX is on my watch list for FDA tomorrow" — and then what? A watch list entry without defined entry criteria, stop levels, and targets is a stock to watch, not a trade to execute. Specific scenarios ("if above $28 then...") convert watching into trading.
Mistake 4: No post-session review. The session provides data; the review converts data into learning. Skipping post-session review keeps the trading experience from becoming cumulative improvement.
Research workflows for day traders are what separate systematic trading from intuition-based gambling. The trader who builds a researched watch list with documented trade scenarios before the session opens, executes those scenarios when conditions are met, and reviews outcomes against plans after the session is building something that compounds. The discipline of systematic research workflow is, itself, an edge — because most traders don't maintain it. The ones who do enter each session with a structural preparation advantage that accumulates over time.
More WebSnips articles that pair well with this topic.
AI knowledge work for day traders is transforming research synthesis, trade journal analysis, and pre-market preparation — but requires strict discipline around real-time data limitations, MNPI compliance, and the boundary between AI-assisted research and AI-generated trading signals.
Knowledge management for day traders is the practice of organizing market research, trade setups, trade journal entries, and strategy development — enabling traders to learn systematically from their own trading history and build an edge that compounds rather than repeating the same mistakes.
A note-taking system for day traders captures trade rationale, execution details, psychological state, and post-trade analysis in structured formats that make pattern recognition possible — turning each trade into a data point that compounds into genuine edge over time.